Bangalore based Sami Labs Limited, a Rs 259 crore transnational health science company, is looking at setting up a manufacturing plant in Andhra Pradesh within the next six months.
Sami Labs is in serious talks with the Andhra Pradesh government in this regard and has been scouting for land in the Visakhapatnam SEZ and other places around Hyderabad.
Speaking to Business Standard, Muhammed Majeed, Managing Director of Sami Labs Limited, said, “We are looking at setting up a nutraceutical manufacturing plant in Andhra Pradesh within the next six months.” We have earmarked a budget of close to Rs 12 crore for this purpose and are looking at employing around 100 people for the plant,” he added.
Sami at present has four manufacturing plants in Karnataka and this will be its first venture in Andhra Pradesh.
Sami, through its subsidiary Sabinsa has its presence in the US, Japan, Australia and South Africa. “We are now planning to set up an office in Brazil by this year – end,” Majeed said. “We are targeting a global turnover of Rs 450 crore by December 2005,” he added.
According to Majeed, Sami is the only company in India that does not test its products on animals. “We use alternative toxicity methods like InVitro non-animal testing that is done on cell lines and eggs. The equipment for this purpose is sourced from California-based InVitro International,” Majeed said. “We have also received an approval from Bhabha Atomic Research Center for radio-labeled studies that will help us in testing the efficacy of our ingredients and products without the use of animals,” he added.